{"id":205429,"date":"2025-01-31T00:00:00","date_gmt":"2025-01-31T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47037383-medtech-peripheral-vascular-devices-market-insights\/"},"modified":"2026-04-16T11:02:31","modified_gmt":"2026-04-16T11:02:31","slug":"47042195-medtech-peripheral-vascular-devices-market-insights-asia-pacific-supplemental","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042195-medtech-peripheral-vascular-devices-market-insights-asia-pacific-supplemental\/","title":{"rendered":"Peripheral Vascular Devices &#8211; Market Insights &#8211; Asia Pacific (Supplemental)"},"content":{"rendered":"<p>The Asia Pacific <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market will grow <span>modestly<\/span> over the forecast period, driven by the high prevalence of <abbr title=\"Peripheral Artery Disease\">PAD<\/abbr>, expanding <abbr title=\"Peripheral Artery Disease\">PAD<\/abbr>-related comorbidities, and rising adoption of premium-priced drug-eluting products. Rising procedure volumes for iliac and lower limb indications and the increasing adoption of endovascular techniques over surgical intervention will also fuel market growth, particularly in China. However, cost constraints in publicly funded healthcare systems and limited reimbursement in the region continue to hinder the adoption of premium-priced devices and limit the pace of revenue expansion.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Peripheral Vascular\">PV<\/abbr> devices in the Asia Pacific region from 2019 through 2033.<\/p>\n","protected":false},"template":"","class_list":["post-205429","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-asia-pacific","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/205429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/205429\/revisions"}],"predecessor-version":[{"id":378915,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/205429\/revisions\/378915"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=205429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}